PA
KITE

Profund Advisors’s Kite Pharma, Inc. KITE Stock Holding History

Profund Advisors’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-22,648
Closed -$4.07M – 1505
2017
Q3 		$4.07M Buy
22,648
+2,103
+10% +$293K 0.17% 98
2017
Q2 		$2.13M Sell
20,545
-816
-4% -$66.6K 0.1% 181
2017
Q1 		$1.68M Buy
21,361
+161
+0.8% +$9.96K 0.08% 238
2016
Q4 		$951K Sell
21,200
-2,796
-12% -$137K 0.04% 459
2016
Q3 		$1.34M Sell
23,996
-385
-2% -$21.5K 0.06% 282
2016
Q2 		$1.22M Sell
24,381
-433
-2% -$21.3K 0.06% 304
2016
Q1 		$1.14M Sell
24,814
-5,621
-18% -$272K 0.06% 306
2015
Q4 		$1.88M Buy
30,435
+2,760
+10% +$194K 0.09% 173
2015
Q3 		$1.54M Buy
+27,675
New +$1.74M 0.09% 185

Profund Advisors's KITE Position: Q4 2017 in Review

Profund Advisors sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 22,648 shares — an estimated $4.07M sold.

Profund Advisors first reported a position in KITE in Q3 2015 and held it in 9 quarters. The position peaked at $4.07M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Profund Advisors reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Profund Advisors sold 22,648 Kite Pharma, Inc. shares in Q4 2017, an estimated $4.07M.
  • Profund Advisors first reported a position in Kite Pharma, Inc. in Q3 2015 and held it in 9 quarters.
  • Profund Advisors's Kite Pharma, Inc. position peaked at $4.07M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Profund Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.